Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 30,900
Avg Vol 41,388
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 40%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Blueberries Medical Corp., a consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia. The company produces and distributes psychoactive and non-psychoactive cannabis derivatives. Blueberries Medical Corp. is based in Vancouver, Canada.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Address:
8500 West Georgia Street, Suite 2200, Vancouver, Canada
Payphonebob
Payphonebob Sep. 1 at 12:28 PM
$BBRRF Q2 2026 financial results came out last night. Revenue Down over 20% compared to same time frame last year. Quarterly Net loss was lowest reported in company history. Not sure if this report will raise or lower stock price? 🤷‍♂️ Does anyone have any idea when this company will have break even financial quarterly results? 3 months, 6 months, 1 year, 2 years, 3 years, ever??🤷‍♂️
1 · Reply
LongRider830
LongRider830 Aug. 27 at 6:52 PM
$BBRRF Notice of Issuance of Proposed Issuance of Listed Securities
0 · Reply
LongRider830
LongRider830 Aug. 25 at 12:16 AM
$BBRRF If the merger were tomorrow, anyone care to make a guess at the valuation of Terraflos and Blueberries? I'll go first: Terraflos: 65,000,000.00 Blueberries: 6,500,000.00 Exchange Ratio: 10:1 Although I don't believe the merger will be until 2027. I hope that CEO Garreton will be kind to the Blueberries retail investors during the merger and valuation period🙏
1 · Reply
unsqueezedlem0n
unsqueezedlem0n Aug. 12 at 5:39 PM
$BBRRF too much dilution here. Not sure where this going to go. Out for now.
7 · Reply
PawPawRico
PawPawRico Aug. 10 at 2:16 PM
$BBRRF Higher highs and lower lows. Now that’s what I’m talking about !
1 · Reply
LongRider830
LongRider830 Aug. 2 at 5:58 PM
$BBRRF Nice website https://blueberriesmed.com/
0 · Reply
LongRider830
LongRider830 Jul. 30 at 10:22 AM
$BBRRF Notice of Issuance of Proposed BBM Securities https://webfiles-primary.thecse.com/filings/neutral/744/af315aea-5210-4183-bca8-88de50774aab?response-content-disposition=inline%3B%20filename%3D%22Form%209-%20Notice%20of%20Issuance%20or%20Proposed%20Issuance%20of%20Listed%20Securities%22%3B%20filename%2A%3DUTF-8%27%27Form%25209-%2520Notice%2520of%2520Issuance%2520or%2520Proposed%2520Issuance%2520of%2520Listed%2520Securities&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=7db34d514465c8f06bca635661a25abb%2F20260730%2Fauto%2Fs3%2Faws4_request&X-Amz-Date=20260730T011804Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=ea721cb5cf06bf1f38d476c0690963a45bcdd1c27997df90788c183cc13d9f16
1 · Reply
LongRider830
LongRider830 Jul. 25 at 5:40 PM
$BBRRF https://youtu.be/AC6yuXNT510?is=cEkEqBqEbGDtlgvS
0 · Reply
LongRider830
LongRider830 Jul. 6 at 9:20 PM
$BBRRF CSE Monthly Progress Report for June 2026:
0 · Reply
LongRider830
LongRider830 Jul. 4 at 11:10 PM
$BBRRF Terraflos bets on longevity: raises US$3.5 million to combine AI, biotechnology and Latin American biodiversity. The startup closed a Pre-Series A round that valued it at US$85 million and will use the funds to expand its brands of supplements, functional foods and skincare while developing a scientific platform focused on preventative health and longevity. The fact that CEO Garreton owns 62% of Blueberries outstanding shares, and is the founder and majority share holder of Terraflos's private shares, it's apparent to me (and AI) that an RTO is in the works to take Terraflos public using the Blueberries shares. Terraflos is valued at US$85 M and Blueberries at US$4.5 M. I'm surprised there is not a stampede to buy Blueberries shares, which is a way to own a piece of Terraflos at a potential of 1:10 or 1:20 reverse split after valuation and settlement. I could be wrong, but I don't think so 🤷🧐
2 · Reply
Latest News on BBRRF
No data available.
Payphonebob
Payphonebob Sep. 1 at 12:28 PM
$BBRRF Q2 2026 financial results came out last night. Revenue Down over 20% compared to same time frame last year. Quarterly Net loss was lowest reported in company history. Not sure if this report will raise or lower stock price? 🤷‍♂️ Does anyone have any idea when this company will have break even financial quarterly results? 3 months, 6 months, 1 year, 2 years, 3 years, ever??🤷‍♂️
1 · Reply
LongRider830
LongRider830 Aug. 27 at 6:52 PM
$BBRRF Notice of Issuance of Proposed Issuance of Listed Securities
0 · Reply
LongRider830
LongRider830 Aug. 25 at 12:16 AM
$BBRRF If the merger were tomorrow, anyone care to make a guess at the valuation of Terraflos and Blueberries? I'll go first: Terraflos: 65,000,000.00 Blueberries: 6,500,000.00 Exchange Ratio: 10:1 Although I don't believe the merger will be until 2027. I hope that CEO Garreton will be kind to the Blueberries retail investors during the merger and valuation period🙏
1 · Reply
unsqueezedlem0n
unsqueezedlem0n Aug. 12 at 5:39 PM
$BBRRF too much dilution here. Not sure where this going to go. Out for now.
7 · Reply
PawPawRico
PawPawRico Aug. 10 at 2:16 PM
$BBRRF Higher highs and lower lows. Now that’s what I’m talking about !
1 · Reply
LongRider830
LongRider830 Aug. 2 at 5:58 PM
$BBRRF Nice website https://blueberriesmed.com/
0 · Reply
LongRider830
LongRider830 Jul. 30 at 10:22 AM
$BBRRF Notice of Issuance of Proposed BBM Securities https://webfiles-primary.thecse.com/filings/neutral/744/af315aea-5210-4183-bca8-88de50774aab?response-content-disposition=inline%3B%20filename%3D%22Form%209-%20Notice%20of%20Issuance%20or%20Proposed%20Issuance%20of%20Listed%20Securities%22%3B%20filename%2A%3DUTF-8%27%27Form%25209-%2520Notice%2520of%2520Issuance%2520or%2520Proposed%2520Issuance%2520of%2520Listed%2520Securities&response-content-type=application%2Fpdf&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=7db34d514465c8f06bca635661a25abb%2F20260730%2Fauto%2Fs3%2Faws4_request&X-Amz-Date=20260730T011804Z&X-Amz-Expires=300&X-Amz-SignedHeaders=host&X-Amz-Signature=ea721cb5cf06bf1f38d476c0690963a45bcdd1c27997df90788c183cc13d9f16
1 · Reply
LongRider830
LongRider830 Jul. 25 at 5:40 PM
$BBRRF https://youtu.be/AC6yuXNT510?is=cEkEqBqEbGDtlgvS
0 · Reply
LongRider830
LongRider830 Jul. 6 at 9:20 PM
$BBRRF CSE Monthly Progress Report for June 2026:
0 · Reply
LongRider830
LongRider830 Jul. 4 at 11:10 PM
$BBRRF Terraflos bets on longevity: raises US$3.5 million to combine AI, biotechnology and Latin American biodiversity. The startup closed a Pre-Series A round that valued it at US$85 million and will use the funds to expand its brands of supplements, functional foods and skincare while developing a scientific platform focused on preventative health and longevity. The fact that CEO Garreton owns 62% of Blueberries outstanding shares, and is the founder and majority share holder of Terraflos's private shares, it's apparent to me (and AI) that an RTO is in the works to take Terraflos public using the Blueberries shares. Terraflos is valued at US$85 M and Blueberries at US$4.5 M. I'm surprised there is not a stampede to buy Blueberries shares, which is a way to own a piece of Terraflos at a potential of 1:10 or 1:20 reverse split after valuation and settlement. I could be wrong, but I don't think so 🤷🧐
2 · Reply
LongRider830
LongRider830 Jul. 4 at 10:19 PM
$BBRRF Technical Evidence Pack https://drive.google.com/file/d/13bUQkUCbsYgM__lv3KlyNpTJ-2ZSQdgC/view?usp=drivesdk
0 · Reply
LongRider830
LongRider830 Jul. 4 at 10:15 PM
$BBRRF Ingredients https://drive.google.com/file/d/19Y4dEBGVHfQI64uPOeg2CapTdWRbeIRT/view?usp=drivesdk
0 · Reply
LongRider830
LongRider830 Jul. 3 at 7:47 AM
$BBRRF Terraflos bets on longevity: raises US$3.5 million to combine AI, biotechnology and Latin American biodiversity https://www.forbesargentina.com/innovacion/terraflos-apuesta-longevidad-levanta-us-35-millones-combinar-ia-biotecnologia-biodiversidad-latinoamericana-n93167
0 · Reply
LongRider830
LongRider830 Jul. 3 at 7:08 AM
$BBRRF Rio de la Plata biotech company Terraflos raises US$3.5 million in investment round https://www.bloomberglinea.com/latinoamerica/argentina/biotech-rioplatense-terraflos-levanta-us35-millones-en-ronda-de-inversion/
0 · Reply
unsqueezedlem0n
unsqueezedlem0n Jun. 30 at 8:23 PM
$BBRRF terraflos had series a offering. Whats that mean for blueberries
1 · Reply
LongRider830
LongRider830 Jun. 12 at 11:31 AM
$BBRRF Blueberries your technical partner in bioactives, backed by Terraflos: https://blueberriesmed.com/
0 · Reply
LongRider830
LongRider830 Jun. 10 at 10:29 PM
$BBRRF CSE Monthly Progress Report for May 2026:
0 · Reply
unsqueezedlem0n
unsqueezedlem0n Jun. 8 at 5:50 PM
$BBRRF this thing does nothing daily, yearly
1 · Reply
Payphonebob
Payphonebob May. 28 at 10:04 PM
$BBRRF Q1 2026 financial results ending 3/31/26 were just released after the closed today 5/28/26. Revenues still lower compared to same time period last year. Not good. Once again very disappointing. 🤷‍♂️
2 · Reply
LongRider830
LongRider830 May. 24 at 10:11 AM
$BBRRF Terraflos
0 · Reply
ipecac007
ipecac007 May. 22 at 11:02 PM
$BBRRF Is traceability the most important ingredient in your pharmaceutical formulation? 🔍 In the healthcare industry, the quality of an ingredient is not defined solely by its purity, but by the strength of the documentation that supports it. When evaluating a pharmaceutical CBD supplier, the real question is: Is your ingredient ready to pass audits, regulatory processes and international standards? 📋 At BLUEBERRIES, we understand that regulatory compliance is not a differential: it is the foundation of patient safety and commercial success. That is why we work on three key pillars: 🧪 Pharmaceutical Grade Documentation Complete Certificates of Analysis (CoA), technical specifications and full lot-to-lot traceability. 🌿 Transparency throughout the chain From the botanical origin to the extraction and purification process, each stage is documented under strict quality and compliance standards. 🛠️ Specialized technical and regulatory support
1 · Reply
ipecac007
ipecac007 May. 22 at 10:59 PM
$BBRRF Brazil is consolidating itself as the epicenter of innovation in Cannabis and Blueberries is present. This week, the eyes of the industry in Latin America are on São Paulo with the celebration of the Cannabis Fair, a key space where medicine, technology, cultivation and business converge in a rapidly expanding market that already exceeds 800,000 patients registered in the country. At Blueberries, we understand that the future of medicinal cannabis applications depends not only on the genetics of the plant, but on the purity and precision of the final ingredient. For this reason, our approach is aligned with the demands of a market as demanding as Brazil's: 🔬 High-Precision Medicinal Applications: We support the development of advanced treatments for human and veterinary health, where cannabinoid consistency is critical to clinical efficacy. ⚡ Supercritical CO₂ Extraction Technology: How do we achieve it? Through state-of-the-art process engineering.
0 · Reply